Cargando…
Plasma Rich in Growth Factors for the Treatment of Cicatrizing Conjunctivitis
PURPOSE: The objective was to evaluate the clinical results obtained from the use of immunosafe plasma rich in growth factors (isPRGF) in the treatment of patients with cicatrizing conjunctivitis (CC) who had not responded to the usual therapy. PATIENTS AND METHODS: This is a retrospective study tha...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306461/ https://www.ncbi.nlm.nih.gov/pubmed/32606577 http://dx.doi.org/10.2147/OPTH.S252253 |